Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RENT.COM.AU LIMITED Capital/Financing Update 2007

Apr 12, 2007

65722_rns_2007-04-12_75753c2e-a73a-451c-b64f-736fbae50570.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

COMPANY ANNOUNCEMENT $(ASK: SLT)$

RELEASE OF SHARES FROM ESCROW

Friday 13th April 2007

Pursuant to ASX Listing Rule 3.10A, and in accordance with the terms of escrow. Select Vaccines Limited hereby announces that the following securities are to be released from escrow.

  • 4,000,000 fully paid Ordinary Shares (SLT) will be released from escrow on 29th April 2007, following expiration of the escrow period.
  • 2,000,000 unquoted options (SLTAS), exercisable at \$0.44 on or before 29 April 2009, will be $\bullet$ released from eserow on $29th$ April 2007, following expiration of the eserow period.

On behalf of the board;

Martin Soust Managing Director

About Select Vaccines Limited

Select Vaccines listed on the ASX on 3 July 2003. It is developing products which identify and protect against infectious diseases of global and national importance and which satisfy the needs of other pharmaceutical and biotechnology companies. Select Vaccines' pipeline includes products targeting 'flu, hepatitis C, and Malaria. It is in partnership with Melbourne's Burnet Institute to commercialize research outcomes in the area of infectious disease. The Burnet Institute, established in 1986, is Australia's leading research organization in the field of infectious diseases caused by viruses and other agents.

Further information can be found on the company's website: www.selectvaccines.com.au.

For further information: Martin Soust (Managing Director) 03 9529 8788